About Protein disulfide-isomerase A6
Protein disulfide-isomerase A6 (PDIA6) is a protein
from Homo sapiens identified by UniProt accession
Q15084, 440 residues long.
MolForge cross-references it against 0 known binders and
228 disease associations.
Target properties
| Protein name | Protein disulfide-isomerase A6 |
| UniProt accession | Q15084 |
| Gene | PDIA6 |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (228)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.52
- self reported educational attainment · score 0.48
- mathematical ability · score 0.42
- schizophrenia · score 0.29
- intelligence · score 0.29
- cognitive function measurement · score 0.28
- vital capacity · score 0.27
- forced expiratory volume · score 0.09
- non-small cell lung carcinoma · score 0.08
- oral squamous cell carcinoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15084-F1 | alphafold | PREDICTED | 86.76 | — |
Amino-acid sequence (440 residues)
MALLVLGLVS CTFFLAVNGL YSSSDDVIEL TPSNFNREVI QSDSLWLVEF YAPWCGHCQR LTPEWKKAAT ALKDVVKVGA VDADKHHSLG GQYGVQGFPT IKIFGSNKNR PEDYQGGRTG EAIVDAALSA LRQLVKDRLG GRSGGYSSGK QGRSDSSSKK DVIELTDDSF DKNVLDSEDV WMVEFYAPWC GHCKNLEPEW AAAASEVKEQ TKGKVKLAAV DATVNQVLAS RYGIRGFPTI KIFQKGESPV DYDGGRTRSD IVSRALDLFS DNAPPPELLE IINEDIAKRT CEEHQLCVVA VLPHILDTGA AGRNSYLEVL LKLADKYKKK MWGWLWTEAG AQSELETALG IGGFGYPAMA AINARKMKFA LLKGSFSEQG INEFLRELSF GRGSTAPVGG GAFPTIVERE PWDGRDGELP VEDDIDLSDV ELDDLGKDEL
Explore Protein disulfide-isomerase A6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets